Pascal Wolter

8.4k citations

86 papers · 2.0k indexed · h-index 26

Impact in

Oncology top 2%
- Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Pulmonary and Respiratory Medicine top 5%
- Renal cell carcinoma treatment

Papers in ⓘ

Oncology 48
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 9
- Cutaneous Melanoma Detection and Management 8
Pulmonary and Respiratory Medicine 41
- Renal cell carcinoma treatment 26

Co-authors: Patrick Schöffski (39 shared papers)Herlinde Dumez (22 shared papers)Brigitte Decallonne (6 shared papers)Benoit Beuselinck (21 shared papers)Cristiana Stefan (3 shared papers)Gregor Verhoef (6 shared papers)Hendrik Van Poppel (9 shared papers)Veerle Foulon (2 shared papers)
Journals: Journal of Clinical Oncology (15 papers)Annals of Oncology (5 papers)Melanoma Research (5 papers)European Journal of Cancer (4 papers)Clinical Genitourinary Cancer (4 papers)
Partner nations: Belgium United States France

In The Last Decade

Pascal Wolter

81 papers receiving 1.9k citations

Peers

Countries citing papers authored by Pascal Wolter

Since Specialization

Citations

This map shows the geographic impact of Pascal Wolter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Wolter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Wolter more than expected).

Fields of papers citing papers by Pascal Wolter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Wolter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Wolter. The network helps show where Pascal Wolter may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Wolter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Wolter Line = papers co-authored together Pascal Wolter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation British Journal of Cancer ·Pascal Wolter, Cristiana Stefan, Brigitte Decallonne, Herlinde Dumez, M Bex, Peter Carmeliet, Patrick Schöffski	2008	157
2	A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours European Journal of Cancer ·Patrick Schöffski, Ahmad Awada, Herlinde Dumez, Thierry Gil, S. Bartholomeus, Pascal Wolter, M. Taton, Holger Fritsch, Patricia Glomb, Gerd Munzert	2011	132
3	Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib Annals of Oncology ·Benoit Beuselinck, Stéphane Oudard, Olivier Rixe, Pascal Wolter, Aurore Blesius, J. Ayllón, Réza Elaidi, Patrick Schöffski, Eduardo Barrascout, Alexandre Morel, Bernard Escudier, H. Lang, Jessica Zucman‐Rossi, Jacques Médioni	2010	115
4	Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI) European Journal of Cancer ·Patrick Schöffski, Jean‐Yves Blay, Jacques De Grève, Étienne Brain, Jean‐Pascal Machiels, Jean‐Charles Soria, Stefan Sleijfer, Pascal Wolter, Isabelle Ray‐Coquard, Christel Fontaine, Gerd Munzert, Holger Fritsch, Gertraud Hanft, Claire Aerts, Jérôme Rapion, Anouk Allgeier, Jan Bogaerts, Denis Lacombe	2010	95
5	Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases British Journal of Cancer ·Benoit Beuselinck, Pascal Wolter, Alexandra Karadimou, Réza Elaidi, Herlinde Dumez, Anne Rogiers, Thomas Van Cann, Ludo Willems, J.J. Body, J. Berkers, Hendrik Van Poppel, Evelyne Lerut, Philip R. Debruyne, Robert Paridaens, Patrick Schöffski	2012	86
6	Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial European Journal of Cancer ·Matteo S. Carlino, Georgina V. Long, Dirk Schadendorf, Caroline Robert, Antoni Ribas, Erika Richtig, Marta Nyakas, Christian Caglevic, Ahmed Tarhini, Christian U. Blank, Christoph Höeller, Gil Bar‐Sela, Catherine Barrow, Pascal Wolter, Haiyu Zhou, Kenneth Emancipator, Erin Jensen, Scot Ebbinghaus, Nageatte Ibrahim, Adil Daud	2018	79
7	Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. PubMed ·Veerle Foulon, Patrick Schöffski, Pascal Wolter	2011	75
8	Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review Annals of Oncology ·Patrick Schöffski, Herlinde Dumez, Paul M. Clément, Ann Hoeben, Hans Prenen, Pascal Wolter, Steven Joniau, Tania Roskams, Hendrik Van Poppel	2006	71
9	Prognostic impact of baseline serum C ‐reactive protein in patients with metastatic renal cell carcinoma ( RCC ) treated with sunitinib British Journal of Urology ·Benoit Beuselinck, Yann Vano, Stéphane Oudard, Pascal Wolter, Robert De Smet, Lore Depoorter, Corine Teghom, Alexandra Karadimou, Jessica Zucman‐Rossi, Philip R. Debruyne, Hendrik Van Poppel, Steven Joniau, Evelyne Lerut, Michiel Strijbos, Herlinde Dumez, Robert Paridaens, Ben Van Calster, Patrick Schöffski	2013	70
10	A Possible Role for MicroRNA-141 Down-Regulation in Sunitinib Resistant Metastatic Clear Cell Renal Cell Carcinoma Through Induction of Epithelial-to-Mesenchymal Transition and Hypoxia Resistance The Journal of Urology ·Joost Berkers, Olivier Govaere, Pascal Wolter, Benoit Beuselinck, Patrick Schöffski, Léon C.L.T. van Kempen, Maarten Albersen, Joost van den Oord, Tania Roskams, Johannes V. Swinnen, Steven Joniau, Hendrik Van Poppel, Evelyne Lerut	2012	55
11	Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study Annals of Hematology ·Nele Vermaete, Pascal Wolter, Gregor Verhoef, Rik Gosselink	2013	52
12	Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma Expert Opinion on Pharmacotherapy ·Patrick Schöffski, Herlinde Dumez, Pascal Wolter, Cristiana Stefan, Agnieszka Woźniak, José Jimeno, Allan T. van Oosterom	2008	46
13	Shrinkage of Thyroid Volume in Sunitinib-Treated Patients with Renal-Cell Carcinoma: A Potential Marker of Irreversible Thyroid Dysfunction? Thyroid ·Aljosja Rogiers, Pascal Wolter, Katya Op de beeck, Marleen Thijs, Brigitte Decallonne, Patrick Schöffski	2010	43
14	MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma International Journal of Cancer ·Rainer Tuominen, Rosalyn Jewell, Joost J. van den Oord, Pascal Wolter, Ulrika Stierner, Christer Lindholm, Carolina Johansson, Diana Lindén, Hemming Johansson, Marianne Frostvik Stolt, Christy Walker, Helen Snowden, Julia Newton‐Bishop, Johan Hansson, Suzanne Egyházi Brage	2014	40
15	Evaluation of thyroid dysfunction as a candidate surrogate marker for efficacy of sunitinib in patients (pts) with advanced renal cell cancer (RCC) Journal of Clinical Oncology ·Pascal Wolter, C Stefan, Brigitte Decallonne, Herlinde Dumez, Steffen Fieuws, Hans Wildiers, Paul M. Clément, Debbie Debaere, A. Van Oosterom, Patrick Schöffski	2008	39
16	Complications des intubations trachéales difficiles dans un service de réanimation médicale Annales Françaises d Anesthésie et de Réanimation ·S. Le Tacon, Pascal Wolter, T. Rusterholtz, Marie‐Line Harlay, S. Gayol, P Sauder, Annick De Jaeger	2000	38
17	Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort Oncotarget ·Jérémie Nsengimana, Jon Laye, Anastasia Filia, Christy Walker, Rosalyn Jewell, Joost J. van den Oord, Pascal Wolter, Poulam M. Patel, Antje Sucker, Dirk Schadendorf, Göran Jönsson, D. Timothy Bishop, Julia Newton‐Bishop	2015	36
18	An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma Oncogene ·Fabian Iltzsche, Katalenić Simon, Sabine Stopp, Grit Pattschull, Stephan Francke, Pascal Wolter, Stefanie Hauser, Daniel J. Murphy, Paloma García, Andreas Rosenwald, Stefan Gaubatz	2016	35
19	Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study Cancer Imaging ·Katja De Paepe, Charlotte Bevernage, Frederik De Keyzer, Pascal Wolter, Olivier Gheysens, Ann Janssens, Raymond Oyen, Gregor Verhoef, Vincent Vandecaveye	2013	34
20	Sarcomatoid Dedifferentiation in Metastatic Clear Cell Renal Cell Carcinoma and Outcome on Treatment With Anti–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Retrospective Analysis Clinical Genitourinary Cancer ·Benoit Beuselinck, Evelyne Lerut, Pascal Wolter, Herlinde Dumez, J. Berkers, Hendrik Van Poppel, Steven Joniau, Raymond Oyen, Liesbeth De Wever, Michiel Strijbos, Robert Paridaens, Patrick Schöffski	2014	32

About Pascal Wolter

Pascal Wolter is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Family Practice and Pathology and Forensic Medicine, having authored 86 papers that have together received 2.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (26 papers), Melanoma and MAPK Pathways (13 papers), Lymphoma Diagnosis and Treatment (11 papers), Cancer Genomics and Diagnostics (10 papers), Renal and related cancers (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (9 papers) and Cutaneous Melanoma Detection and Management (8 papers). The work is most often cited by research in Oncology (1000 citations), Pulmonary and Respiratory Medicine (790 citations), Family Practice (50 citations), Cancer Research (308 citations) and Molecular Biology (817 citations). Pascal Wolter has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Patrick Schöffski, Herlinde Dumez, Brigitte Decallonne, Benoit Beuselinck, Cristiana Stefan, Gregor Verhoef, Hendrik Van Poppel, Veerle Foulon, M Bex and Evelyne Lerut. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Melanoma Research, European Journal of Cancer and Clinical Genitourinary Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact